Thelansis

 Clear cell renal cell carcinoma (CCRCC) is a renal cortical tumor characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar or acinar growth pattern accompanied by intricate vasculature. The disease may progress without noticeable symptoms in its early stage, but as it advances, symptoms such as hematuria, fatigue, fever, lump, flank pain, and weight loss may arise. Certain risk factors such as smoking, obesity, hypertension, kidney disease requiring dialysis, exposure to workplace toxins, and prolonged use of pain relievers can increase the chances of developing CCRCC. In some cases, CCRCC may cause blood clots in the renal vein of the affected kidney. The incidence rate of CCRCC increases with age, peaks in individuals aged 60 to 79, and is higher in males than females. ·        The overall incidence rate of ccRCC in the USA was estimated to be 3.59 cases per 100,000 population. Thelansis’s “Clear Cell Renal Cell Ca...

 Clear cell renal cell carcinoma (CCRCC) is a renal cortical tumor characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar or acinar growth pattern accompanied by intricate vasculature. The disease may progress without noticeable symptoms in its early stage, but as it advances, symptoms such as hematuria, fatigue, fever, lump, flank pain, and weight loss may arise. Certain risk factors such as smoking, obesity, hypertension, kidney disease requiring dialysis, exposure to workplace toxins, and prolonged use of pain relievers can increase the chances of developing CCRCC. In some cases, CCRCC may cause blood clots in the renal vein of the affected kidney. The incidence rate of CCRCC increases with age, peaks in individuals aged 60 to 79, and is higher in males than females. ·        The overall incidence rate of ccRCC in the USA was estimated to be 3.59 cases per 100,000 population. Thelansis’s “Clear Cell Renal Cell Ca...